AddLife AB
OTC:ADDLF
Intrinsic Value
AddLife AB engages in the ownership and acquisition of companies in niche segments under the healthcare sector. [ Read More ]
The intrinsic value of one ADDLF stock under the Base Case scenario is 76.1 USD. Compared to the current market price of 42 USD, AddLife AB is Undervalued by 45%.
Valuation Backtest
AddLife AB
Run backtest to discover the historical profit from buying and selling ADDLF stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
AddLife AB
Current Assets | 3.6B |
Cash & Short-Term Investments | 272m |
Receivables | 1.6B |
Other Current Assets | 1.8B |
Non-Current Assets | 9.1B |
Long-Term Investments | 9m |
PP&E | 1.1B |
Intangibles | 8B |
Other Non-Current Assets | 112m |
Current Liabilities | 4.3B |
Other Current Liabilities | 4.3B |
Non-Current Liabilities | 3.5B |
Long-Term Debt | 2.9B |
Other Non-Current Liabilities | 596m |
Earnings Waterfall
AddLife AB
Revenue
|
9.7B
SEK
|
Cost of Revenue
|
-6B
SEK
|
Gross Profit
|
3.7B
SEK
|
Operating Expenses
|
-3B
SEK
|
Operating Income
|
672m
SEK
|
Other Expenses
|
-482m
SEK
|
Net Income
|
190m
SEK
|
Free Cash Flow Analysis
AddLife AB
ADDLF Profitability Score
Profitability Due Diligence
AddLife AB's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
AddLife AB's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
ADDLF Solvency Score
Solvency Due Diligence
AddLife AB's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
AddLife AB's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ADDLF Price Targets Summary
AddLife AB
According to Wall Street analysts, the average 1-year price target for ADDLF is 57.54 USD .
Shareholder Return
ALIF B Price
AddLife AB
Average Annual Return | 50.84% |
Standard Deviation of Annual Returns | 96.99% |
Max Drawdown | -86% |
Market Capitalization | 12.4B SEK |
Shares Outstanding | 121 857 100 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
AddLife AB engages in the ownership and acquisition of companies in niche segments under the healthcare sector. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2015-03-16. The firm markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The firm operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The firm operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one ADDLF stock under the Base Case scenario is 76.1 USD.
Compared to the current market price of 42 USD, AddLife AB is Undervalued by 45%.